Listing & Compliance Notices

REMARK HOLDINGS, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(3), 5550(b)).

“October 26, 2023, we received a staff determination letter from Nasdaq indicating that we did not regain compliance with the Continued Listing Standards. Accordingly, unless we request an appeal of Nasdaq’s determination, our common stock is subject to delisting. We will appeal Nasdaq’s delisting determination to a Hearings Panel (the “Panel”). Such hearings are generally scheduled within approximately 30 days of the request. Our common stock will continue to be listed and traded on the Nasdaq Capital Market pending a decision by the Panel.”

Bluescape Opportunities Acquisition Corp. received a nyse delisting notice notice regarding minimum bid price (rules 802.01D).

“September 28, 2023, the New York Stock Exchange (the “NYSE”) notified the Company that the NYSE determined to commence proceedings to delist the Company’s warrants from the NYSE and that trading in the Company’s warrants would be suspended immediately, due to trading price levels pursuant to Section 802.01D of the NYSE Listed Company Manual. As a result of the expected expiration of the warrants described above, the Company does not intend to appeal the NYSE’s determination. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caus”

GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding other (rules 5635(d)).

“October 26, 2023, First Wave BioPharma, Inc. (the “Company”, “we” or “us”) received written notice (the “Notification Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with the shareholder approval requirement set forth in Nasdaq Listing Rule 5635(d), which requires prior shareholder approval for transactions, other than public offerings, involving the issuance of 20% or more of an issuer’s pre-transaction shares outstanding at less than the applicable Minimum Price (as defined in List”

Acutus Medical, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5810(c)(3)(A)).

“ymbol “AFIB”. The Nasdaq Capital Market is a continuous trading market that operates in substantially the same manner as The Nasdaq Global Market and listed companies must meet certain financial requirements and comply with Nasdaq’s corporate governance requirements. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), if a company listed on The Nasdaq Capital Market is not deemed in compliance before the expiration of the 180-day compliance period, it will be afforded an additional 180-day compliance period, provided that on the 180th day of the first compliance period it meets the applicable marke”

Troika Media Group, Inc. received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).

“October 26, 2023, the Nasdaq notified the Company that the Company had regained compliance with Nasdaq Listing Rule 5250(c)(1) . The Staff’s notification indicated that this matter is now closed.”

HeartCore Enterprises, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 26, 2023, HeartCore Enterprises, Inc. (the “Company”) received written notice (the “Bid Price Notice”) from the Nasdaq Listing Qualification Department (the “Nasdaq Staff”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) for continued listing on the Nasdaq Capital Market. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market under the symbol “HTCR,” and the Company is curr”

Allarity Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“October 27, 2023, we received notification from the Nasdaq Listing Qualifications staff that it has determined that the bid price of our Common Stock has closed at less than $1 per share over the previous 30 consecutive business days, and, as a result, does not comply with Listing Rule 5550(a)(2) (the “Rule”). Further, the staff also noted that we effected an 1:35 reverse stock split on March 24, 2023, and an 1:40 reverse stock split on June 28, 2023. Because we effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one, we wil”

Edible Garden AG Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 24, 2023, Edible Garden AG Incorporated (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company no longer meets Nasdaq Listing Rule 5550(a)(2), which requires listed companies to maintain a minimum bid price of at least $1 per share. Nasdaq Listing Rule 5810(c)(3)(A) provides a compliance period of 180 calendar days, or until April 22, 2024, in which to regain compliance with the minimum bid pric”

CURO Group Holdings Corp. received a nyse deficiency notice notice regarding minimum bid price (rules 802.01C).

“October 27, 2023, Curo Group Holdings Corp. (the “Company”) received notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is no longer in compliance with the NYSE continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual due to the fact that the average closing price of the Company’s common stock, par value $0.10 per share (the “Common Stock”), over the prior 30 consecutive trading days was below $1.00 per share. As required by the NYSE, the Company plans to notify the NYSE of its intent to cure the price deficiency and restore its compl”

AUDDIA INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 24, 2023, the Company received a written notice from the Nasdaq staff indicating that the Company had not regained compliance with the Bid Price Requirement and was not eligible for the additional 180 calendar day compliance period. As a result, the Staff determined to delist the Company’s Common Stock from Nasdaq, unless the Company timely requests an appeal of the Staff’s determination to a Hearings Panel (the “Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. The Company intends to request a hearing before the Panel to appeal the October notice an”

KYNTRA BIO, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“October 24, 2023, FibroGen, Inc. (“FibroGen”) received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market notifying FibroGen that for the last 30 consecutive business days the bid price of FibroGen’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq listing rule 5450(a)(1). The notification received has no immediate effect on the listing of FibroGen’s common stock on Nasdaq. In accordance with listing rule 5810(c)(3)(A), FibroGen has 180 calendar days, or until April 22, 2024, to r”

INTRUSION INC received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

“October 26, 2023, Intrusion Inc. (the “Company”) received a letter from the Listing Qualifications Staff of Nasdaq (the "Staff Determination") notifying the Company that, based upon the Company's non-compliance with the $35 million market value of listed securities requirement ("MVLS") for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Marketplace Rule 5550(b)(2), the Company's securities are subject to delisting from Nasdaq unless the Company requests a hearing before a Nasdaq Hearings Panel (the “Hearings Panel"). The Company plans to timely request a hearing before a”

MariaDB plc received a nyse deficiency notice notice regarding market value (rules 802.01C).

“June 28, 2023 that it was not in compliance with Section 802.01C of the Manual because the average closing price of the Company’s ordinary shares was less than $1.00 over a consecutive 30 trading-day period. In connection with the June notice, the Company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard with respect to the deficiency under Section 802.01C. The Company is currently within the six-month cure period for this deficiency following receipt of the June notice.”

MariaDB plc received a nyse deficiency notice notice regarding market value (rules 802.01B).

“ng standards. The Company is currently considering its next steps regarding compliance. As previously disclosed in the Company’s Current Report on Form 8-K filed on September 22, 2023, the Company received written notice from the NYSE on September 19, 2023 that it was not in compliance with Section 802.01B of the Manual because the average global market capitalization of the Company over a consecutive 30 trading-day period was less than $50 million and, at the same time, the Company’s last reported stockholders’ equity was less than $50 million. In connection with the September notice, the Com”

MariaDB plc received a nyse deficiency notice notice regarding audit committee (rules 303A.01, 303A.07(a)).

“October 23, 2023, the Company received written notice (the “ Notice ”) from the NYSE that the Company was not in compliance with the corporate governance listing standards set forth in Section 303A.01 and 303A.07(a) of the Manual because the Company does not have a majority of independent directors and does not have three independent members on the audit committee. If the Company does not cure the deficiencies by October 30, 2023, a below compliance (“BC”) indicator will be disseminated over the consolidated tape and displayed on the Company’s NYSE profile starting November 1, 2023. Such indic”

Gardiner Healthcare Acquisitions Corp. received a nasdaq noncompliance notice notice regarding shareholders (rules 5550(a)(3), 5810(c)(2)(C)).

“October 24, 2023, Gardiner Healthcare Acquisitions Corp. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company no longer meets Listing Rule 5550(a)(3), which requires listed companies to maintain a minimum of 300 public holders (the “Total Holders”). Nasdaq Listing Rule 5810(c)(2)(C) provides the Company with a period of 45 calendar days, or until December 8, 2023 (the “Compliance Date”), to submit a plan to regain compliance. Pursuant to Nasdaq Listing Rule 5810(c)(2)(B)(i), if Nasd”

Akili, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 24, 2023, Akili, Inc. (the “Company”), received a letter from the Listing Qualifications Staff (the “Nasdaq Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the 30 consecutive business days from September 11, 2023, through October 23, 2023, the bid price of the Company’s common stock, par value $0.0001 per share (“common stock”) had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company’s c”

Integral Acquisition Corp 1 received a nasdaq deficiency notice notice regarding other (rules 5450(a)(2)).

“October 24, 2023, Integral Acquisition Corporation I, a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market (the “Minimum Total Holders Rule”). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Com”

Transcode Therapeutics, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5815(a)(2)).

“October 26, 2023, the Company received written notice from Nasdaq (the “October Notification Letter”) that the Panel had granted the Company an exception from compliance with the Stockholders Equity Requirement and extension of continued listing until January 22, 2024, subject to the following: 1. On or before November 14, 2023, the Company shall provide a detailed update to the Panel regarding its meeting the Stockholders’ Equity Requirement; and 2. On or before January 22, 2024, the Company shall provide an update to the Panel on how it demonstrates long-term compliance with the Stockholders”

Palladyne AI Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“October 24, 2023, Sarcos Technology and Robotics Corporation (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that, based on the closing bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for the last 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $”

Beachbody Company, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

“ss A common stock, par value $0.0001 per share (“Class A Common Stock”), at an exercise price of $11.50 per share, and listed to trade on the NYSE under the symbol “BODY WS” (the “Warrants”) and (b) immediately suspend trading in the Warrants due to “abnormally low” price levels pursuant to Section 802.01D of the NYSE Listed Company Manual. To effect the delisting, the NYSE will apply to the Securities and Exchange Commission to delist the Warrants upon completion of all applicable procedures. Trading in the Company’s Class A Common Stock will be unaffected and will continue on the NYSE under”

Onfolio Holdings, Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 25, 2023, Onfolio Holdings Inc. (the “ Company ”) received a written notification (the “ Notice ”) from the Listing Qualifications Staff of The NASDAQ Stock Market (“ NASDAQ ”) stating that the Company is not in compliance with NASDAQ Listing Rule 5550(a)(2) because for the last 30 consecutive business days the closing bid price of the Company’s common stock was below the $1.00 per share minimum required for continued listing on NASDAQ. The Notice has no immediate effect on the listing or trading of the Company’s common stock on the NASDAQ Capital Market. As stated in the Notice, NASDA”

AKUMIN INC. received a other delisting notice notice regarding other.

“October 23, 2023, trading in the Company’s securities on the Toronto Stock Exchange (“TSX”) was suspended. In connection with the suspension of its securities, the Company received a written notice from TSX (the “TSX Notice”) notifying the Company that TSX is reviewing the eligibility of the Company’s securities for continued listing on TSX pursuant to the expedited review process (the “Expedited Review Process”) set forth under Part VII, Section 707 of the TSX Company Manual (the “Manual”). The Company is currently undergoing the Expedited Review Process because it meets the insolvency delist”

AKUMIN INC. received a nasdaq delisting notice notice regarding other (rules 5800).

“October 17, 2023, the Company received a written notification (the “Staff Delisting Determination”) from Nasdaq’s Listing Qualifications Department notifying the Company that unless the Company appealed Nasdaq’s delisting determination to a Nasdaq Hearings Panel (the “Hearings Panel”) in compliance with the procedures set forth in the Nasdaq Listing Rule 5800 Series by 4:00 p.m. Eastern Time on October 24, 2023, (i) Nasdaq would suspend trading of the Common Stock at the opening of business on October 26, 2023 and (ii) Nasdaq would schedule the Common Stock for delisting and file a Form 25-NSE”

AMERICAN REBEL HOLDINGS INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 23, 2023, the Registrant received a written notification (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Registrant was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the Registrant’s closing bid price for its common stock, par value $0.001 per share, was below $1.00 per share for the last thirty (30) consecutive business days. Nasdaq’s notice has no immediate effect on the listing of the common stock on The Nasdaq Capital Market and, at this time, the common stock will continue to trade on The Nasdaq Capital Market under the symbol “AREB”. Pur”

Knightscope, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“October 26, 2023, Knightscope, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”), as the minimum bid price of the Company’s Class A Common Stock has been below $1.00 per share for the last 31 consecutive business days. The notification of noncompliance has no immediate effect on the listing or trading of the Company’s Class A Common Stock on The Nasdaq Global Market. The Company has 180 calendar days, or until April 23, 2024, to regain co”

ATECH (PARENT) RESOLUTION CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 24, 2023, Akoustis Technologies, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive trading days, the Company was no longer in compliance with the $1.00 Minimum Bid Price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market (the “Bid Price Requirement”). The Notice has no immediate effect on the listing of the Company’”

Presurance Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(1)(C), 5810(c)(3)(D)).

“October 23, 2023, Conifer Holdings Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that for the past 30 consecutive business days prior to the date of the letter, the market value of “publicly held” shares of the Company was less than $5.0 million, which does not meet the requirement for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(1)(C) (the “MVPHS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(D), the Company has been provided a period of 180 calendar days, or until April 22, 2024, to r”

Firsthand Technology Value Fund, Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(1)(C)).

“July 28, 2023, Firsthand Technology Value Fund, Inc. (the “Fund”) received a letter (the “Notice”) from the Nasdaq Stock Market (“Nasdaq”) indicating that, based on the Fund’s market value of publicly held shares for the prior 31 consecutive business days, the Fund no longer met the requirement to maintain a minimum market value of publicly held shares of $5,000,000, as set forth in Nasdaq Listing Rule 5450(b)(1)(C). After considering various alternatives, the Fund determined it would be futile to attempt to satisfy the listing requirements for Nasdaq. The Fund’s common stock stopped trading b”

STREAMLINE HEALTH SOLUTIONS INC. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 24, 2023, Streamline Health Solutions, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market indicating that the closing bid price of the Company’s common stock, par value $0.01 per share, has been below the minimum bid price of $1.00 per share for the previous 30 consecutive business days, which is required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), Nasdaq has provided the Company with 180”

DSS, INC. received a nyse_american deficiency notice notice regarding other (rules 1003(f)(v)).

“October 20, 2023, DSS, Inc. (the “Company”) received a letter (the “Letter”) from the staff of NYSE American LLC (the “Exchange”) stating that the Company’s securities have been selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the NYSE American Company Guide, the Company’s continued listing is predicated on it effecting a reverse stock split of its common stock or otherwise demonstrating sustained price improvement within a reasonable period of time, which the Exchange has determined to be no later than April 20, 2024. However, the Excha”

Mountain Crest Acquisition Corp. V received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(3)(C)).

“May 18, 2023, the Company received a letter from Nasdaq stating that the Company failed to maintain the minimum 1,100,000 publicly held shares as required by the Nasdaq continued listing rules, and (iii) June 27, 2023, the Company received a letter from Nasdaq stating that the Company’s publicly held shares failed to maintain a minimum Market Value of Publicly Held Shares (“MVPHS”) of $15,000,000 which is a requirement for continued listing on The Nasdaq Global Market in accordance with Nasdaq Listing Rule 5450(b)(3)(C) based upon the Company’s MVPHS for the 30 consecutive business days prior”

Thunder Bridge Capital Partners IV, Inc. received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

“October 24, 2023, Thunder Bridge Capital Partners IV, Inc. (the “ Company ”), received a letter (the “ Total Shareholders Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires the Company to maintain at least 400 total holders for continued listing on the Nasdaq Global Market. The Total Shareholders Notice stated that the Company has until December 8, 2023 to provide Nasdaq with a plan to regain compliance. If the plan is accepted, Nasdaq may grant an ex”

Rent the Runway, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 20, 2023, Rent the Runway, Inc. (the “ Company ” ) received a letter (the “ Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until April 17, 2024, to regain compliance. The letter st”

Edgio, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).

“April 27, 2023, that for the preceding 30 consecutive business days, the closing bid price of its common stock was below $1.00 per share and therefore the Company did not comply with the minimum closing bid price requirement for continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1). The Company was given a compliance period of 180 calendar days, or until October 25, 2023, to regain compliance with the minimum bid price requirement. However, in connection with the transfer to the Nasdaq Capital Market, the Company will be eligible for an additional compliance”

PHP Ventures Acquisition Corp. received a nasdaq compliance regained notice regarding market value (rules 5550(b)(2), 5550(a)(3), 5800).

“March 6, 2023 to April 14, 2023), was below the required minimum of $35 million for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b)(2) (the “ MVLS Rule ”). In accordance with the MVLS Notice, the Company had one hundred eighty (180) calendar days (or until October 16, 2023) to regain compliance. The MVLS Notice stated that Nasdaq will close the matter and provide written confirmation that the Company has achieved compliance with the MVLS Rule if at any time before October 16, 2023, the Company’s MVLS closes at $35 million or more for a minimum of ten (10) consecutive business day”

Onyx Acquisition Co. I received a nasdaq deficiency notice notice regarding shareholders (rules 5450(a)(2)).

“October 24, 2023, Onyx Acquisition Co. I (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, since the Company’s Form 10-Q for the period ended June 30, 2023 reported total holders below the round lot holder requirement under Nasdaq Listing Rule 5450(a)(2) (the “Round Lot Requirement”), the Company no longer complies with Nasdaq’s Listing Rules. The Notice does not impact the listing of the Company’s Class A ordinary shares, par value $0.0001 per share (“Class A o”

LQR House Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“isting Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an”

Professional Diversity Network, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“October 20, 2023 (the “Panel Monitor”), pursuant to which, if at any time before the end of the monitor period, Nasdaq staff or the Panel determines that the Company has ‎failed to meet the minimum bid price requirement in Listing Rule 5550(a)(2) (the “Bid Price Rule”) (that is, the Company has had a closing bid price under $1.00 ‎for a period of 30 consecutive trading days), or any other requirement for continued listing on Nasdaq, Nasdaq ‎staff will issue a delist determination‎ ‎and a new hearing will be scheduled. On October 20, 2023, the Company received an end of monitor letter from the”

MARIN SOFTWARE INC received a nasdaq noncompliance notice notice regarding minimum bid price.

“April 26, 2023, Marin Software Incorporated (the “Company”) received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with certain of Nasdaq’s continued listing requirements, as the closing bid price of the Company’s shares had been below $1.00 per share for the previous 30 consecutive business days. The Company was given a period of 180 calendar days, or until October 23, 2023, to regain compliance with the minimum bid price requirement. In response, the Company submitted an application to transfer the listing of its shares from the Nasdaq”

PRECISION BIOSCIENCES INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5450(a)(1)).

“April 24, 2023, the Company received a letter from Nasdaq indicating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1) because the closing bid price per share for the Company’s common stock had closed below $1.00 for the previous 30 consecutive business days (the “Minimum Bid Price Requirement”). In response, the Company filed an application to transfer the listing of its common stock from the Nasdaq Global Select Market to the Nasdaq Capital Market. As a result of the Approval, the Company has been granted an additional 180-day grace period, or until April 22, 2024, t”

D-Wave Quantum Inc. received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

“October 20, 2023 , D-Wave Quantum Inc. (the “Company,” “we,” “us” or “our”) was notified by the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s common stock was less than $1.00 over a consecutive 30 trading-day period. The notice does not result in the immediate delisting of the Company’s common stock from the NYSE. On October 24, 2023 , the Company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued li”

MOBIX LABS, INC received a nasdaq delisting notice notice regarding shareholders (rules 5550(a)(3)).

“the “Hearing”), in connection with the Company’s previously reported failure to maintain a minimum Market Value of Listed Securities (“MVLS”) for the Company’s ordinary shares above the $35 million minimum MVLS requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”) and (ii) the Company’s previously reported failure to satisfy Listing Rule 5550(a)(3), which requires the Company to have at least 300 “Public Holders” (as defined in Listing Rule 5005(a)(36)) for continued listing on The Nasdaq Capital Market (the “Minimum Public Holder”

MOBIX LABS, INC received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

“the “Hearing”), in connection with the Company’s previously reported failure to maintain a minimum Market Value of Listed Securities (“MVLS”) for the Company’s ordinary shares above the $35 million minimum MVLS requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”) and (ii) the Company’s previously reported failure to satisfy Listing Rule 5550(a)(3), which requires the Company to have at least 300 “Public Holders” (as defined in Listing Rule 5005(a)(36)) for continued listing on The Nasdaq Capital Market (the “Minimum Public Holder”

SEP Acquisition Corp. received a nasdaq compliance regained notice regarding market value (rules 5550(b)(2)).

“(the “Company”) received a letter from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with Nasdaq’s $35 million minimum Market Value of Listed Securities (“MVLS”) requirement , and the Company is therefore in compliance with The Nasdaq Capital Market’s listing requirements. As a result,”

Aterian, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 24, 2023, Aterian, Inc. (the “Company”) issued a press release announcing that the Company received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) granting the Company a 180-day extension, or until April 22, 2024, to regain compliance with Nasdaq’s $1.00 minimum bid price requirement as set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule"). A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference. This notice has no immediate effect on the listing or trading of the Company's common stock on The”

Staffing 360 Solutions, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“October 18, 2023, the Staff notified the Company that it had regained compliance with the Listing Rule with respect to the Q1 Form 10-Q. On October 18, 2023, the Company received a notice from the Staff notifying the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Listing Rule as a result of its failure to file the Q2 Form 10-Q in a timely manner (the “Staff Determination”). Unless the Company requests an appeal of the Staff Determination pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series, trading of the Company’s common sto”

MariaDB plc received a nyse deficiency notice notice regarding board independence (rules 303A.01).

“October 20, 2023, the Company further notified the NYSE that it was deficient with respect to Section 303A.01 of the Manual as well. Previously, each of Alexander Suh, Christine Russell, Harold Berenson, and Theodore Wang tendered their respective resignations from the Company’s board of directors (the “Board”) and, to the extent applicable, all committees thereof. Following the resignations, the Board was fixed at four directors, with Michael Fanfant and Yakov Zubarev joining Chief Executive Officer Paul O’Brien and independent director Jurgen Ingels . As a result of those Board changes, the”

MariaDB plc received a nyse deficiency notice notice regarding audit committee (rules 303A.07(a), 303A.01).

“October 17, 2023, the Company notified the New York Stock Exchange (“NYSE”) that the Company is deficient in meeting the requirement under Section 303A.07(a) of the NYSE Listed Company Manual (the “Manual”), which requires NYSE audit committees to be comprised of at least three independent directors. On October 20, 2023, the Company further notified the NYSE that it was deficient with respect to Section 303A.01 of the Manual as well. Previously, each of Alexander Suh, Christine Russell, Harold Berenson, and Theodore Wang tendered their respective resignations from the Company’s board of direct”

AERWINS Technologies Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1)).

“October 18, 2023, AERWINS Technologies Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined to delist the Company’s common stock and warrants from The Nasdaq Global Market due to the Company not having regained compliance with Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Requirement”) during the 180-calendar-day period (the “Compliance Period”) following the deficiency letter the Company received from the Staff on April 20, 2023, regarding”